Narcolepsy: a review of evidence for autoimmune diathesis.

作者: John Logan Black

DOI: 10.1080/02646830500381492

关键词: AntibodyDiseaseHLA-DQB1Cerebrospinal fluidCataplexyNarcolepsyInternal medicineClinical trialImmunologyAutoimmunityEndocrinologyPsychology

摘要: Sporadic narcolepsy with cataplexy is a disabling disease that strongly associated the major histocompatibility class II allele HLA DQB1*0602 and characterized by profound reduction in cerebrospinal fluid (CSF) concentration of hypocretin 1 levels. This article provides comprehensive review evidence neurologic autoimmunity pathogenic basis cataplexy. Despite this evidence, specific antibody markers for have been elusive. Clinical trials using intravenous immunoglobulin infusions recent onset led to improvement some patients. Future research must focus on elucidation immune early ameliorative treatments narcolepsy.

参考文章(79)
J. D. Parkes, K. Welsh, N. Langdon, C. Lock, Immune Factors in Narcolepsy in the United Kingdom Springer, Berlin, Heidelberg. pp. 158- 171 ,(1988) , 10.1007/978-3-642-83387-8_14
Gaetan Poirier, Jacques Montplaisir, Francine Decary, Daniele Momege, Andre Lebrun, HLA antigens in narcolepsy and idiopathic central nervous system hypersomnolence. Sleep. ,vol. 9, pp. 153- 158 ,(1986) , 10.1093/SLEEP/9.1.153
Emmanuel Mignot, R Hayduk, J Black, FC Grumet, C Guilleminault, HLA DQB1*0602 is Associated With Cataplexy in 509 Narcoleptic Patients Sleep. ,vol. 20, pp. 1012- 1020 ,(1997) , 10.1093/SLEEP/20.11.1012
Lois E. Krahn, Nancy L. Slocumb, V. Shane Pankratz, Paul A. Fredrickson, Michael H. Silber, John L. Black, Denise L. Walker, Rajeswari K. Avula, HLA DQB1*0602 positive narcoleptic subjects with cataplexy have CSF lgG reactive to rat hypothalamic protein extract. Sleep. ,vol. 28, pp. 1191- 1192 ,(2005)
E. Mignot, X. Lin, J. Arrigoni, C. Macaubas, F. Olive, J. Hallmayer, P. Underhill, C. Guilleminault, W. C. Dement, F. C. Grumet, DQB1*0602 and DQA1*0102 (DQ1) Are Better Markers Than DR2 for Narcolepsy in Caucasian and Black Americans Sleep. ,vol. 17, pp. S60- S67 ,(1994) , 10.1093/SLEEP/17.SUPPL_8.S60
Luis Dominguez-Ortega, Rafael J. Salin-Pascual, Elena Díaz-Gállego, Narcolepsy-like symptoms in a patient with down syndrome and without obstructive sleep apnea. Sleep. ,vol. 26, pp. 285- 286 ,(2003) , 10.1093/SLEEP/26.3.285
Yves Dauvilliers, Bertrand Carlander, Nicolas Molinari, Alex Desautels, Michele Okun, Mehdi Tafti, Jacques Montplaisir, Emmanuel Mignot, Michel Billiard, Month of birth as a risk factor for narcolepsy. Sleep. ,vol. 26, pp. 663- 665 ,(2003) , 10.1093/SLEEP/26.6.663
Leja Dolenc-Grosel, David B Vodusek, The importance of HLA DQB1*0602 typing in Slovene patients with narcolepsy. Cellular & Molecular Biology Letters. ,vol. 7, pp. 359- ,(2002)
Lois E. Krahn, V. Shane Pankratz, Lawrence Oliver, Bradley F. Boeve, Michael H. Silber, Hypocretin (orexin) levels in cerebrospinal fluid of patients with narcolepsy: relationship to cataplexy and HLA DQB1*0602 status. Sleep. ,vol. 25, pp. 733- 736 ,(2002) , 10.1093/SLEEP/25.7.733
Christelle Peyron, Juliette Faraco, William Rogers, Beth Ripley, Sebastiaan Overeem, Yves Charnay, Sona Nevsimalova, Michael Aldrich, David Reynolds, Roger Albin, Robin Li, Marcel Hungs, Mario Pedrazzoli, Muralidhara Padigaru, Melanie Kucherlapati, Jun Fan, Richard Maki, Gert Jan Lammers, Constantin Bouras, Raju Kucherlapati, Seiji Nishino, Emmanuel Mignot, None, A mutation in a case of early onset narcolepsy and a generalized absence of hypocretin peptides in human narcoleptic brains Nature Medicine. ,vol. 6, pp. 991- 997 ,(2000) , 10.1038/79690